Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved hair growth in three patients with alopecia.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Low-dose oral minoxidil effectively improves male hair loss with mild side effects.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Solanum nigrum extract may help regrow hair.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

TrichoScan® is a reliable tool for measuring hair growth, providing quicker and more consistent results than manual methods.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Endocrine therapies for cancer significantly increase the risk of hair loss.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

Men with androgenetic alopecia (hair loss) are more likely to have fatty liver disease than those without hair loss.

Combining PRP and minoxidil is more effective for hair loss than using either alone.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Using a special laser and platelet-rich plasma together is safe and improves hair growth in men with hair loss.

Urinary PSA could be an early marker for enlarged prostate.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

Adenosine led to higher patient satisfaction than minoxidil for hair loss treatment.